Last updated on June 2006

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Metastatic Melanoma
  • Age: Between 18 - 75 Years
  • Gender: Male or Female
  • Other:
    histological diagnosis of metastatic melanoma (stage IV)
    progressive disease after first-line chemotherapy or immuno-chemotherapy
    Karnofsky-index > 60%
    informed consent

You may not be eligible for this study if the following are true:

  • Uvea melanoma
    another primary malignancy except basal cell carcinoma or cervical carcinoma in situ
    severe and/or uncontrolled medical disease (diabetes mellitus, cardiac insufficiency)

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.